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Ann Arbor 
A methodological approach was established for the 
study of ligand binding to multiple opioid receptors in 
slices from rat brain striatum. Specific binding of 
radiolabeled opiates was resolved from total binding 
with enantiomers or excess unlabeled ligand. Equilib- 
rium binding of triated etorphine, dihydromorphine, 
and ethylketocyclazocine, and competitive displace- 
ment of [3H]etorphine and [3H]dihydromorphine by 
the unlabeled opiates were used to assess both high 
and low affinity receptor sites. The high-affinity bind- 
ing components of the radiolabeled opiates were char- 
acterized by linear Scatchard plots, Kd values of 2.8- 
3.7 nM, and binding site densities of 180-297 fmol/mg 
protein. The displacement of [3H]etorphine by mor- 
phine and ethylketocyclazocine displayed Hill coeffi- 
cients of 0.62 and 0.47, respectively, and revealed 
receptor sites with much lower affinities than those 
described by the direct binding of these opiates. On 
the other hand, both morphine and ethylketocyclazo- 
cine displaced [3H]dihydromorphine with similar high 
potencies (apparent Kd's, 3-4 nM). The results sup- 
port the feasibility of using brain slices as a cellular 
preparation to study opioid receptor mechanisms. 
Key words: multiple opioid receptors, rat brain, 
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INTRODUCTION 
During recent years, marked advances have been 
made in describing the binding of opiates to multiple 
opioid receptors in isolated brain membranes [e.g., Gil- 
lan and Kosterlitz, 1982; James and Goldstein, 19841. 
Since various tissue constituents such as ions and nucleo- 
tides markedly influence the interaction of opiates with 
their receptor [Blume, 1978; Blume et al, 1979; Chang 
et al, 19831, in numerous studies these components were 
included in the medium of the binding assay with isolated 
membranes. As an alternative, a procedure for the as- 
sessment of opioid receptor binding in vivo was devel- 
oped based on an assay in tissue homogenates isolated 
from rats injected with radiolabeled opiates. Using this 
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approach, binding profiles and potencies different than 
those obtained in isolated membranes were described 
[Rosenbaum et al, 19841. In addition, autoradiographic 
studies with selective radiolabeled opiates have described 
the distinctive, differential localization of the opioid re- 
ceptor types in brain [Herkenham and Pert, 1981; Good- 
man and Snyder, 19821. 
The study of ligand interaction with opioid receptor 
in isolated intact cells imposes considerable methodolog- 
ical difficulties, particularly the involvement of free li- 
gand in processes other than receptor binding. Therefore, 
in studies with the NG108-15 neuroblastoma-glioma hy- 
brids, containing only the delta receptor, the cells were 
homogenized prior to the binding assay [e.g., Simantov 
et al, 19821. The assay of opioid receptor binding was 
also described in brain slices [Davis et al, 1977; Jacobson 
and Wilkinson, 19841 and, recently, the binding of 
['HH]naloxone to opioid receptor in freshly isolated brain 
cells was reported [Rogers and El-Fakahany, 19851. 
However, in these studies multiple opioid receptors were 
not considered, and only a narrow range of low concen- 
trations of the radiolabeled ligands was used. In brain 
membranes, we have investigated both the equilibrium 
binding and kinetics of ligand association and dissocia- 
tion as approaches to characterize the interaction of opi- 
ates with multiple receptor binding sites [Fischel and 
Medzihradsky, 198 1, 19861. In that tissue, we have also 
described the resolution of multiple opioid receptors on 
the basis of (a) their differential sensitivity towards so- 
dium [Medzihradsky et al, 19841, @) receptor alkylation 
[Clark and Medzihradsky, 19861, and (c) receptor cou- 
pling to brain GTPase [Clark et al, 1986; Clark and 
Medzihradsky, 19871. 
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Considering the information obtained with isolated induced adenylate cyclase by opiates in brain slices 
membranes, the known regulatory roles of tissue constit- [Barchfeld et al, 19821, a coupling process abolished in 
uents, and the different characteristics of opiate binding isolated membranes [Katz and Catravas, 19771. In the 
in vivo, it was of interest to investigate the heterogeneity present study we have now investigated ligand binding to 
of ligand interaction with opioid receptor in an intact opioid receptor in slices from rat brain striatum, using 
cellular system from brain. The information obtained kinetic approaches suitable to assess multiple binding 
from such studies is essential for the characterization of sites with diverging affinities for different types of 
these receptors in vivo, e.g., by the use of positron opiates. 
emission tomography [Fros; et al, 19841. Brain slices 
remesent a convenientlv available cellular DreDaration in 
~ 
MATERIALS AND METHODS 
1 .  
w k h  cell-cell interaciion, e.g., between neurons and Materials 
glia, is preserved. Thus, they complement the use of ['HIDihydromorphine (['HIDHM), 71 Wmmol; 
primary cultures of neural cells from brain [Fischel and [3H]ethylketocyclazocine (['HIEKC), 20 Ci/mmol; and 
Medzihradsky, 19851. We have previously described the ['4C]inulin, 1.7 mCi/g, were obtained from New En- 
receptor-mediated inhibition of prostaglandin E (PGE)- gland Nuclear Corporation (Boston, MA). [3H]etorphine 
A. RESOLUTION OF BINDING 
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Fig. 1. A: Concentration-dependent binding of [3H]opiates 
in striatal slices. Slices, suspended in oxygenated artificial 
cerebrospinal fluid medium, were incubated for 15 min at 
25°C in the absence or presence of 10 pM unlabeled mor- 
phine, etorphine, or ethylketocyclazocine. Subsequently, 
[3H]DHM, r3H]ET, or [3H]EKC were added at the concentra- 
tions indicated. After incubation for 20 min (ET) or 40 min 
(DHM and EKC) at 25°C to attain binding equilibrium, the 
assay was terminated by rapid filtration. Specific binding (0) 
was defined as the difference between total binding (A)  and 
nonsaturable binding (O), and was determined as described in 
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Materials and Methods. Presented are the mean values of 
results obtained in three experiments each carried out in dupli- 
cate. B: Displacement of bound [3H]DHM by levorphanol and 
dextrorphan. Slices were incubated for 15 min as described 
above in the presence of either levorphanol (0 )  or dextror- 
phan (0) at the concentrations indicated. Subsequently, 
[3H]DHM was added to give a final concentration of 0.25 nM 
(top panel), 2 nM (middle panel), or 20 nM (lower panel). 
After additional incubation for 40 min, the assay was termi- 
nated by rapid filtration. Shown are the results of a represen- 
tative experiment carried out in duplicate. 
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(['HIET), 37 Ci/mmol, was purchased from Amersham 
Corporation (Arlington Heights, IL) . The radiochemical 
purity of these compounds was listed as greater than 
98 % . This information from the supplier was verified by 
thin-layer chromatography in solvent systems recom- 
mended by the manufacturers. The unlabeled opiates 
were obtained through the Drug Abuse Basic Research 
Center at the University of Michigan. Biochemicals were 
obtained from Sigma Chemical Company (St. Louis, 
MO). Other chemicals were of the reagent grade. The 
nylon cloth of specific mesh sizes (Nitex) was purchased 
from Tetco, Inc. (Elmsford, NY). 
Determination of Protein 
The method of Lowry et a1 [ 195 I ]  was applied. In 
order to compensate for potential interference by com- 
ponents of the assay systems [Peterson, 19791, the stan- 
dards of crystallized, liophylized bovine serum albumin 
were prepared with the same constituents present in the 
samples being assayed. 
Determination of Cellular Potassium and Sodium 
After incubation under the conditions described for 
opioid receptor binding, the suspension of slices was 
filtered on 110-pm mesh Nitex disks (cut out from cor- 
responding sheets with a cork borer of appropriate di- 
ameter) supported by underlying Whatman 934AH glass- Opioid Receptor Binding in Brain Slices 
Male SPrague-DawleY rats weighing 180 g were fiber filters. Following washing on the filter with 4 x 5 
decapitated; the brains were quickly excised and trans- ml of ice-cold 0.3 M sucrose, PH 7.4., the Nitex disks 
ferred to 2 4 ° C .  The striata were dissected and cut into were transferred to 1.5-ml polypropylene microcentri- 
400-pm-thick slices Using a Brinkmann-McIlwain tissue fuge tubes. After the addition of 400 deionized 
slicer. By means of fire-polished Pasteur Pipettes, the water, the tissue was disrupted by sonication, using a 
slices were dispersed (one-half striata per sample) in 1.9 Bronson sonifier with a microtip at power output 6 for 
ml of oxygenated artificial cerebrospinal fluid medium, 45 set. The Nitex disks remained intact and were re- 
pH 7.4 and 333 mOsmo1 of the following ComPosition moved at this point. After aliquots were removed for the 
(mM): NaCI, 125.0; KCI, 1.8; CaC12, 1.3; MgS04, 1.2; determination of protein, the sonicated tissue was di- 
K2PO4, 1.2; NaHC03, 25.0; glucose, 10.0. Deionized gested with 50 p1 70% HN03 for 2 hr at 60°C. Upon 
water or an excess of unlabeled opiate (to determine cooling to room temperature, 5 ml of 15 mEq/liter of 
specific binding) was added in a volume of 50 and LiCl were added as internal standard, and the concen- 
the slices were allowed to incubate for 15 min at 25°C trations of K+ and Na+ were determined by flame pho- 
with constant bubbling of 95 % CO2-5 % 0 2  through the tometry. To satisfy the requirement of sensitivity, approx- 
medium. The rate of gassing was adjusted to maintain imately 2 mg of protein per sample were required. The 
the pH at 7.4 throughout the experiment. Subsequently, results are expressed as pEq of cellular K+ or Na' per 
the radiolabeled opiate was added and the Suspension of mg protein, and were obtained by subtracting the c0r-e- 
slices were incubated at 25 "C for varying lengths of time sponding extracellular concentration, represented by the 
as indicated in the respective figure legends. The incu- extracellular space and ion concentration in the incuba- 
bation was terminated by quickly filtering the sample tion medium, from the total ion content of the slices. 
through glass-fiber filters (Reeve-Angel 934AH) which 
had been soaked with water and rinsed with 0.9% ice- Determination of Extracellular Space 
cold NaCl saturated with n-amyl alcohol [Medzihradsky, Slices were incubated in the presence of 0.5 pCi of 
19761. Following washing with 3 X 4 ml of cold 0.9% ['4C]inulin under the experimental condition of the bind- 
NaCl, the filters were placed in a plastic scintillation Vial ing assay. The incubation was terminated by filtering the 
and the tissue digested with 2 ml of NaOH for 1 hr at slices on Whatman 934AH glass fiber filters, previously 
60°C. After cooling to room temperature, 2 ml of 1 % washed with deionized water and 0.9% NaCl. Following 
deoxycholate were added, and the samples were placed washing with 4 x 4 ml of ice-cold 0.9% NaCl, the filters 
in a shaking water bath for 30 min. Subsequently, ali- were transferred to polypropylene counting vials, and 
quots were removed for scintilIation counting and protein digested for 60 min at 60°C with 1 ml of 0.25 N NaOH. 
determination. Aliquots of the digests were taken for the determination 
Specific [3Hlligand binding was defined either as of protein and radioactivity. Inulin space was expressed 
the difference between binding in the presence of D- and as microliters per mg protein. 
L-opiate (e.g., dextrorphan and levorphanol), or the dif- 
ference between binding in the absence and presence of 
10 pM of the corresponding unlabeled opiate. That con- 
centration was obtained from displacement curves estab- 
lished for all concentrations of the radiolabeled ligands 
used in this study (Fig. 1). The evaluation of these ap- 
proaches is described under Results. 
Characteristics of the Binding Assay 
The viability of brain slices was ascertained by their 
ability to accumulate Kf and maintain a positive gradient 
relative to the incubation medium throughout the incu- 
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bations [Fischel and Medzihradsky, 19851. The slices pertinent observations with brain membranes, the exper- 
suspended in a medium with the composition of cerebro- imental temperature of 30”C, and the fact that the non- 
spinal fluid accumulated potassium to a concentration of specific binding of naltrexone was saturated already at 
0.50 pEq/mg protein. During incubations at 25°C of up 30 min. As shown in a different study carried out with 
to 120 min, the ratio between the mean intracellular and 20-pm brain sections, the opioid receptor binding of 0.5- 
extracellular concentrations of potassium was 46, and the 6.0 nM [3H]-naloxone was equilibrated in 30 min at 
mean extracellular space was 2.73 0.86 pl/mg protein room temperature [Geary and Wooten, 19831. 
(corresponding to approximately 273 pl/g tissue wet 
weight). These characteristics compare favorably with 
such data reported for freshly isolated brain tissue IMc- Quantitiation of Opioid Receptor Binding 
Ilwain and Rodnight, 19621-and slices [Pappius ei al, The concentration dependence of r3H]ET, 
1962; Goodman et al, 19731. [3H]DHM, and r3H]EKC binding showed that below 
Opioid receptor binding was defined as the differ- 0.25 nM of tritiated opiate the extent ligand binding was 
ence between [3H]opiate bound in the absence and pres- insufficient for accurate quantitiation, whereas at concen- 
ence of an appropriate excess [Fischel and Medzihradsky, trations above 20 nM the increasing contribution of non- 
198 I] of the corresponding unlabeled opiate. Thus, for specific interactions masked the receptor binding. Within 
each of the three ligands used, [3H]DHM, [3H]ET, and the concentration range of 0.25-20 nM, the Scatchard 
[3H]EKC, total ligand binding was resolved into satura- plots for specific binding of all three radiolabeled opiates 
ble, receptor-related, and nonspecific, linear binding were linear, with & ’ s  in the low nanomolar range (Fig. 
components (Fig. 1A). The specificity of saturable bind- 2 and Table I). The binding data were also analyzed by 
ing was ascertained by the use of enantiomers [Fischel the semilogarithmic plots shown as insets in Figure 2 
and Medzihradsky, 19811. As shown for [3H]DHM (mu- [Klotz, 19823. These curves are characterized by an in- 
selective), profiles of radiolabeled ligand displacement flection point at 50% of B,,,,, and are useful to confirm 
(“binding windows”) were established using the mu- the number of binding sites obtained from respective 
selective stereoisomer levorphanol (active) and its inac- Scatchard analyses, particularly in view of extensive non- 
tive counterpart dextrorphan (Fig. 1B). With increasing specific binding at high ligand concentrations. 
concentrations of the radiolabeled ligand, reflecting the In addition to Scatchard analysis, the binding data 
range within which Scatchard analysis was carried out, were evaluated by NONLIN, a weighted, nonlinear least- 
the area of the window representing stereospecific bind- squares regression analysis program, for fit to binding 
ing decreased owing to the increased proportion of non- models of one saturable site, one saturable binding site 
specific binding. At appropriate concentrations of plus one linear binding component, two saturable binding 
levorphanol and dextrorphan, the binding window was sites, and two saturable binding sites plus one linear 
open to its widest extent because of the minimal and binding component [Fischel and Medzihradsky, 1981, 
maximal displacement of [3H]DHM by dextrorphan and 19861. The appropriateness of each binding model was 
levorphanol, respectively. Throughout the concentration evaluated by comparing the sum of weighted squared 
range of [3H]DHM used, this maximal stereospecific deviations using the F ratio test [Boxenbaum et al, 19741. 
binding was equivalent to maximal saturable binding as This evaluation showed that our data were best fit to a 
determined with an excess (10 pM) of unlabeled mor- binding model of one population of saturable sites (Table 
phine. Thus, specific saturable binding of [3H]DHM was I). In a previous study, [3H]naloxone bound to opioid 
considered representative of (stereospecific) opioid re- receptors in slices from cortex and hyppocampus of the 
ceptor binding. Analogous analyses were carried out for mouse brain with Kd’s of 7.4 and 1.0 nM, and B,, 
[3H]EKC (used as a putative Kappa opiate) with the values of 136 and 177 fmol/mg protein, respectively 
kappa enantiomers UM 1071R (active) and UM 1071s [Jacobson and Wilkinson, 19841. 
(inactive) [Medzihradsky et al, 19841. Specific binding 
of [3H]ET (nonselective) was determined only with an 
appropriate excess of the unlabeled opiate. Heterogeneity of Opiate Binding in Brain Slices 
The attainment of binding equilibrium within 40 In the experiments on equilibrium binding of radio- 
min at 25°C was tested with the lowest (0.25 nM) and labeled opiates, the large contribution of nonspecific as- 
highest (20 nM) concentrations at which direct binding sociations precluded assessment of the low-affinity 
of the radiolabeled opiates was investigated (data not binding components seen in isolated brain membranes 
shown). In a previous study, specific binding of 2 nM [e.g., Fischel and Medzihradsky, 19811. Therefore, the 
[3HH]naloxone in slices from mouse hippocampus reached approach of competitive displacement was applied [Mol- 
equilibrium only after 120 min [Jacobson and Wilkinson, inoff et al, 19811. In these experiments, the slices were 
19841. Such slow equilibration is surprising considering incubated with 1 nM of the nonselective opiate L3H]ET 
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Fig. 2. Scatchard analysis of opiate binding in striatal slices. 
Following preincubation for 15 min, the slices were incubated 
in artificial cerebrospinal fluid medium with 0.25-20 nM of 
[3H]DHM (A), [3H]ET (B), or [3H]EKC (C) to reach binding 
equilibrium, as described in the legend to Figure 1. The inset 
depicts an alternate presentation of the data characterized by 
an inflection point at 0.5 B,, [Klotz, 19821. Presented are 
the mean values obtained in three experiments carried out in 
duplicate. The statistical evaluation of the data is described in 
the legend to Table I .  
TABLE I. Parameters of r3H10~iate Bindine in Brain Slices* 
Brnax 
(fmol/mg K d  
'H-Opiate protein) (nM) 
3H-dihydromorphine 180 f 5 3.70 f 0.1 I 
'H-etorphine 297 f 17 2.83 f 0.21 
'H-ethy lketocyclazocine 280 f 30 3.61 f 0.31 
*Specific ['Hlopiate binding (0.25-20 nM) was determined as 
described in Materials and Methods. The listed values correspond to 
the Scatchard plots shown in Figure 2, and were obtained by applying 
NONLIN, a weighted nonlinear least-squares regression analysis 
program as described [Fischel and Medzihradsky, 19861. For each 
['Hlopiate, the estimated parameters (I&: equilibrium dissociation 
constant, B,,,: maximal ligand binding) are based on 20-24 data 
points obtained in three experiments. Shown are the means and 
standard deviations. 
manner characteristic of equivalent, noninteracting sites 
(Fig. 3), yielding an EC50 of 4.6 nM and a Hill coeffi- 
cient of 0.94 (Table 11). In contrast, the displacement 
curves obtained with morphine and EKC had shallow 
slopes spanning approximately 4 log units of unlabeled 
ligand concentration (Fig. 3 )  and resulted in Hill coeffi- 
cients of 0.62 and 0.47, respectively. The high EC50 
values for morphine and EKC (Table 11) indicated that in 
contrast to the approach of direct binding (Fig. 2), low- 
affinity sites were being revealed. It is of interest to note 
the similarity between the apparent & values for etor- 
phine obtained from direct binding and ligand displace- 
ment. On the other hand, the & values generated by the 
displacement of bound [3H]ET by morphine and EKC 
were considerably higher than those obtained by direct 
binding (Tables I1 and I). 
In order to compare the selectivity of morphine and 
EKC in binding to opioid receptors, the displacement of 
[3H]DHM by these two opiates was investigated. Mor- 
phine displaced [3H]DHM over two log units of ligand 
concentration, characteristic of a population of equiva- 
lent, noninteracting sites (Fig. 4). In accordance, the Hill 
coefficient was close to unity (Table 11). The value of & 
app, calculated from the corresponding EC50, was mark- 
edly similar to that determined by direct binding of 
[3H]DHM (Tables I and 11). L-EKC also displaced 
[3H]DHM in a manner characteristic of a one-site bind- 
ing model, yielded a Hill coefficient of 0.8, and dis- 
played an affinity similar to that of morphine (Fig. 4, 
Table 11). In comparing the EC50 values in Table 11, it 
should be noted that in contrast to DL-morphine and DL- 
etorphine, the L-isomer of EKC was used. 
and with increasing concentrations of either unlabeled 
etorphine, morphine, or ethylketocyclazocine (EKC), 
added concurrently with the radiolabeled ligand. 
['HlEtorDhine was displaced bv unlabeled etomhine in a 
DISCUSSION 
This study explored the suitability of brain slices as . -  
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Fig. 3 .  Displacement of bound [3H]ET by morphine, etor- 
phine, and ethylketocyclazocine. Brain slices were incubated 
for 15 min as described in the legend to Figure 1. Subse- 
quently, 1 nM [’HH]ET and unlabeled morphine (top panel), 
etorphine (middle panel), or ethylketocyclazocine (bottom 
panel) were added simultaneously at the concentrations indi- 
cated. After renewed incubation for 3.5 min, the assay was 
terminated by rapid filtration as described in Materials and 
Methods. The insets depict the data as a Hill plot. Each 
experiment was carried out in duplicate, and the results were 
averaged. Shown are all the averages obtained in three exper- 
iments. The curves were drawn with the aid of the weighted, 
nonlinear least-squares regression analysis program BMDX- 
8.5, obtained from the Health Science computing Facility, Uni- 
versity of California, Los Angeles. 
with opioid receptor. In view of the high density of opioid 
receptors in striatum, this brain region was selected as 
the tissue source [Pert and Snyder, 19731. The slices 
accumulated potassium against its concentration gradient, 
a stringent criterion of cellular viability [Fischel and 
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was previously demonstrated [Barchfeld et al, 1982) by 
the opioid-receptor-mediated inhibition of PGE-induced 
adenylate cyclase under experimental conditions similar 
to those used for ligand binding in the present work. In 
contrast to slices, PGE stimulation of the enzyme and its 
sensitivity to opiates was abolished in isolated brain 
membranes [Katz and Catravas, 19771. 
In a previous study on opioid receptor binding of 
[3H]naloxone in slices from mouse brain [Jacobson and 
Wilkinson, 19841 Iigand concentration was limited to 12 
nM, thus excluding the assessment of low affinity sites, 
i.e., hampering the assessment of opioid receptor heter- 
ogeneity. In the present work, the approach of competi- 
tive displacement, applied in addition to direct 
equilibrium binding of the radiolabeled opiates, allowed 
the study of ligand binding to receptor sites with widely 
diverging affinities. 
The results of direct receptor binding suggested that 
radiolabeled etorphine, dihydromorphine, and EKC 
bound to a population of noninteracting sites with similar 
high affinities. The corresponding Scatchard plots were 
linear with no indication of cooperativity . Computer fit- 
ting to binding models with more than one site did not 
improve the resolution of the data. Furthermore, 1 nM 
r3H]ET was displaced by increasing concentrations of 
unlabeled etorphine in a homogenous manner, as indi- 
cated by an appropriate displacement profile and Hill 
coefficient. On the other hand, the displacement profiles 
of [3H]ET by morphine and EKC were characterized by 
shallow slopes, spanning approximately 4 log-units of 
unlabeled drug concentration and by Hill coefficients of 
0.62 and 0.47, respectively. The relatively high EC50 
values for the two opiates (Table 11) indicated that in 
addition to the high-affinity sites (Kd’s approximately 2- 
5 nM) measured by direct binding (Fig. 2), sites with 
lower affinity were revealed in the displacement experi- 
ments (Fig. 3 ) .  Apparently, morphine and EKC share 
with etorphine a population of high-affinity sites, but are 
recognized with much lower affinity by an additional set 
of sites labeled by [’HIET. 
It is of interest that the EC50 values for the dis- 
placement of [3H]etorphine by morphine and EKC (Table 
11) were similar to the respective IC50’s of these opiates 
in inhibiting PGE-induced adenylate cyclase in brain 
slices [Barchfeld et al, 19821. Since the binding and 
inhibition of adenylate cyclase were measured undei 
comparable experimental conditions, it seems reasonable 
to postulate that the low-affinity sites may be involved in 
the coupling of opioid receptor to adenylate cyclase. In 
that respect, recent experiments have shown that folfow- 
ing alkylation of the high-affinity opioid receptor sites in 
brain membranes, the binding of ligands to the residual 
low-affinity sites still induced the stimulation of low-K, 
GTPase [Clark and Medzihradsky, 19861. 
In isolated brain membranes from the rat and guinea 
Medzihradsky, 19851. Functional integriiy of the slices pig, etorphine was described as a nonselective ligaid that 





TABLE 11. Displacement of Bound 13H]ET and [3H]DHM by Opiates in Brain 
Slices* 
EC50 Kd aPP Hill 
Displacing ligand (nM) ( n y  coefficient 
A. [3H]ET binding 
Etorphine 6.3 4.6 0.94 
Morphine 126.0 92.5 0.62 
L-Ethylketocyclazocine 63. I 49.3 0.47 
B .  ['HIDHM binding 
Morphine 5.0 3.9 0.88 
L-Ethyl ketocyclazocine 3.5 2.1 0.80 
*The listed values correspond to the plots shown in Figures 3 and 4. The apparent 
ligand dissociation constant (Kd app) was calculated according to the following formula 
[Cheng and Prusoff, 19731: 
EC50 
= 1 + [L]/kd 
Statistical information is listed in the legends to Figures 3 and 4. 
1 
7 
-LOO [MORPHINE] (M) 
bound to mu, kappa, and delta receptors [Fischel and 
Medzihradsky, 1986; Clark and Medzihradsky, 1987; 
Kosterlitz and Patterson, 19801. On the other hand, as 
determined by the in vivo technique, ['HIET bound to 
sites with mu-receptor properties [Rosenbaum et al, 
19841, but was displaced by morphine with a potency 
that was more than 140-fold lower than that for EKC 
[ Rosenbaum et al, 19851. 
In a comparative study, involving the measurement 
of analgesia and opiate dependence in the mouse [Von 
Voigtlander and Lewis, 19821, EKC displayed lower 
kappa selectivity than the newly introduced ligand 
U50,488 [Von Voigtlander et al, 19831. In rat brain 
membranes, the characteristics of EKC binding were 
similar to those of naltrexone [Fischel and Medzihradsky, 
1 a I I I 19811 and etorphine [Fischel and Medzihradsky, 19861, 
10 9 8 7 6 5 4 3 opiates of limited binding selectivity. However, in behav- 
1, ' 
I 3 - 
0 z -LOG [MORPHINE] (M) 
3 
idral studies, EKC displayed typical kappa agonist activ- 
ity [Woods et al, 19791, and has subsequently frequently 
been used as a kappa ligand [e.g., Garzon et al, 19841. 
Nonetheless, the in vivo binding of ['HIEKC was char- 
acterized by low affinity and large scatter of the data. 
The binding was saturable and reflected interaction with 
These discrepancies between the results obtained with 
isolated brain membranes, brain slices, and rats in vivo 
underline the need for additional studies of opioid recep- 
Fig. 4. Displacement of bound 13H]DHM by morphine and 
ethylketocyclazocine. The slices were preincubated and then 
incubated as described in the legend to Figure 3 with 1 nM 
['HIDHM and morphine (A) or ethylketocyclazocine (B) at 
the concentrations indicated. The insets depict Hill plots of the 
data. Shown are the averages of duplicate determinations ob- 
tained in three experiments (0 ,  A, H). 
s 
z 8. 
kappa, mu, and delta sites [Rosenbaum et al, 198.51. I00 
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